Medical costs of CKD in the Medicare population - Wikidata - awgldk - TriplyDB

Medical costs of CKD in the Medicare population

Medical costs of CKD in the Medicare population

http://www.wikidata.org/entity/Q37119893

about

Kidney disease: new technologies translate mechanisms to cure Self-management interventions in stages 1 to 4 chronic kidney disease: an integrative review Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy.Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002-2011.Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis.Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases Renal Oxygenation in the Pathophysiology of Chronic Kidney Disease.A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England.Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.Risk factors of gender for renal progression in patients with early chronic kidney disease.ASN Presidential Address 2013: innovation and individualization--the path forward for nephrology.Acute kidney injury-epidemiology, outcomes and economics.The therapeutic potential of C-peptide in kidney disease: a protocol for a systematic review and meta-analysis.PATTERNS OF HEALTHCARE ENCOUNTERS EXPERIENCED BY PATIENTS WITH CHRONIC KIDNEY DISEASE.Estimating One-Year Risk of Incident Chronic Kidney Disease: Retrospective Development and Validation Study Using Electronic Medical Record Data From the State of Maine.Dialysis in the Elderly and Impact of Institutionalization in the United States Renal Data System.Economic burden of comorbid chronic kidney disease and diabetes.Emergency Department Use among Patients with CKD: A Population-Based Analysis.Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.Prevalence of chronic kidney disease in Peruvian primary care setting Progression to Stage 4 chronic kidney disease and death, acute kidney injury and hospitalization risk: a retrospective cohort study.Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.A Cost-Benefit and Accurate Method for Assessing Microalbuminuria: Single versus Frequent Urine Analysis.Assessing the prevalence of chronic kidney disease in the community: Estimating glomerular filtration rate is the Achilles heel Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)Are Ambulatory Care-Sensitive Conditions the Fulcrum of Hospitalizations for CKD Patients?Occupational Heat Stress and Kidney Health: From Farms to Factories.Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.The economic burden of kidney disorders in Korea.Is the kidney yet another potential end-organ casualty of obstructive sleep apnea?

P2860

Q26825227-C8BFCC5D-10B3-463F-B7EC-2E0255884C59 Q26829238-6335BA4F-181B-4E65-A608-EFDDA2E749ED Q30238784-0F367423-11B4-463B-8FE9-0A98D4CB5406 Q33627670-3B9C2DCE-C983-4C5D-98FF-61EF3FD344B2 Q33717422-E6778697-4175-4DFE-8DA5-D34B051F47E4 Q33790497-13762BA9-7669-474C-8EC5-B5320EB117FA Q33821915-5A3E6CF3-B3FF-4B33-B200-9CF7FBF70BDD Q33838866-CA8DF25D-E9B5-40B9-A19E-FFAE4FBCC31B Q33843362-086B1D7D-B4F7-4916-B873-665A3FC7DDE3 Q34445136-2D1833BA-B08A-44A9-99FA-46F724C50F5C Q35583850-DEF41D2F-BE21-4CA6-AD3E-8A59ECE7BCD8 Q36104887-61B752AC-9C00-4B14-BA04-86142A18D46F Q36240905-E59477DF-4447-421E-851F-9E435818C6CF Q36300946-2C9175A2-BA08-481F-820C-83AFF413E75A Q36543089-4588264F-A092-4FF3-8AEF-78DF21FFC806 Q37356124-8CF21983-60D7-4ADE-8D5D-00790DB7A4CB Q37605595-4492FE57-785C-4DDB-8237-0442D9D930FD Q37733628-DA250F97-3905-4657-BF8E-5229F840E4B8 Q38180360-B3CA5685-474D-48A3-ACBF-37CE5D0FF518 Q38216760-E7BC69F3-86B8-4410-B5B3-47DB1D31CF36 Q38401780-BEC22DF9-481C-4C3C-93DE-9BED2870CDC8 Q38659530-D08C87FC-7094-48E2-8747-8971B97F0AD7 Q38680704-6E217E5A-5067-41AB-ACA0-82F873617111 Q38995684-08FB0F1F-5A1D-4579-BDB5-C6BC969B7E45 Q39001156-1FAE9B6E-11DD-4382-9B81-D8ABC50E3857 Q39207535-D8AF9E12-F26A-4B72-9BA6-2CF5BE202893 Q39238366-4BDA1696-D595-4A6E-A4D0-22825BCE680E Q39427234-CE6D4FDF-D4FE-4044-978A-77AB3D413109 Q40972894-414291F1-006D-4D77-ADDC-36B24ABA0229 Q41064012-9581818B-BDBB-450C-B36A-A606DB86928F Q41108622-7915445D-2DAF-414A-8532-CB35EE919F14 Q41573480-5EF1BF04-ACC7-4E37-B0AB-FD6456AF5705 Q41861563-7DD7862D-586E-41B5-A068-E9930DF13DA4 Q42056144-8BB1875A-6CF1-414C-8283-D2F553097C22 Q42377373-AB4D44B3-92F3-4C88-8999-504137433DC4 Q44082295-A6A506E1-3092-4938-8707-3760151FF014 Q47124892-11FF692A-FE85-40A7-B1A4-222BEC7A0198 Q47136990-90EFA789-CDD2-442B-A30E-E89A8F71E781 Q47718812-3E005E31-E6AD-4782-851F-1DBAEB4E9C09 Q47931393-C16A7D81-CE27-4AD6-B25F-EBDB9CC58547

P2860

Medical costs of CKD in the Medicare population

http://www.wikidata.org/entity/Q37119893

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Medical costs of CKD in the Medicare population

@en

Medical costs of CKD in the Medicare population.

@nl

type

label

Medical costs of CKD in the Medicare population

@en

Medical costs of CKD in the Medicare population.

@nl

prefLabel

Medical costs of CKD in the Medicare population

@en

Medical costs of CKD in the Medicare population.

@nl

P1433

Q37119893-D43BD5D4-050E-454C-95E2-5CACF3ADF20C

P1476

Q37119893-2708B5E8-B101-444A-BAE8-72D2C33B428E

P2093

Q37119893-181E9C40-9393-4CBA-9F28-CC05A0C6E6B3

Q37119893-34C2460C-9063-4EAE-A40B-703C38796DFF

Q37119893-85DBFC44-421F-4B15-BE44-4886CF14A5B5

Q37119893-8E5C07CA-A882-408B-B556-D59A4C9B9677

Q37119893-CAC7D68D-3981-49AE-9394-1F78CEC4F0F9

P2860

Q37119893-09F1EEC5-2F7F-488C-B4F3-190BFFD2D69A

Q37119893-12B525F0-7C22-4065-B4CA-63E4B6930160

Q37119893-134B0DE6-357B-4B7A-81ED-DEC02851B851

Q37119893-3319D893-3769-41EA-81D0-1336C4AF2B15

Q37119893-48AA9A75-DD66-4058-AF88-5CCD2F2B4B5F

Q37119893-7C5474A4-9056-4C0E-9AC5-40D65B2825CC

Q37119893-93DDFE39-9737-4F49-BA58-3A3E8D77A338

Q37119893-A1B8DF0D-39EB-4F24-B065-EA0DAC40FB79

Q37119893-A29921AC-0240-4F40-B2EA-9A172C670D95

Q37119893-A8A5ACC9-C490-4C37-B395-D669E0EDC02B

P304

Q37119893-ABEEECFB-8463-44DE-AFB2-48E8E4BB9237

P31

Q37119893-7D256E5E-9159-4F57-B636-4584126BAEB5

P356

Q37119893-4D196CB8-0DD6-43FD-8870-13947BF35C74

P433

Q37119893-4ABE837D-D13A-4090-B7DB-9489F9D87C28

P478

Q37119893-D3C2DD51-EB56-423B-B21C-8E0E1118BC2A

P50

Q37119893-D5AFE2E3-306E-4DFC-B4AB-8D0A2DEB62C9

P577

Q37119893-78CB0F61-2913-4BE1-A72C-9672EFB836EA

P698

Q37119893-DD2506F4-5D08-44F6-A48F-2D3951C23420

P932

Q37119893-77939DFA-7559-4C22-A54F-3009644CF997

P356

P1433

Journal of the American Society of Nephrology

P1476

Medical costs of CKD in the Medicare population

@en

P2093

Amanda A Honeycutt

http://www.w3.org/2001/XMLSchema#string

Desmond Williams

http://www.w3.org/2001/XMLSchema#string

Kumiko Imai

http://www.w3.org/2001/XMLSchema#string

Thomas J Hoerger

http://www.w3.org/2001/XMLSchema#string

Xiaohui Zhuo

http://www.w3.org/2001/XMLSchema#string

P2860

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Prevalence of chronic kidney disease in the United States

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Chronic kidney disease and the risk of end-stage renal disease versus death.

Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes

Nationally representative medical costs of diabetes by time since diagnosis.

Comparing cost-of-illness estimates from alternative approaches: an application to diabetes.

Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population.

The direct medical cost of type 2 diabetes.

Estimating log models: to transform or not to transform?

P304

1478-1483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2012040392

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23907508

http://www.w3.org/2001/XMLSchema#string

P932

3752941

http://www.w3.org/2001/XMLSchema#string